{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:01:47Z","timestamp":1784548907185,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glucocorticoids (GCs) are used to treat multiple pathologies; however, their prolonged use leads to numerous adverse effects. Non-steroidal selective agonists of the glucocorticoid receptor (SEGRAs) have the potential to be a worthy substitute for dexamethasone (DXM). The aim of this study was to compare the effects of SEGRAs and DXM on the cell composition and extracellular matrix of normal brain tissue, with a focus on the acute short-term effects of these drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>C57Bl\/6 mice (n = 28) received an intraperitoneal injection of SEGRA (CpdA or CpdA-03) or DXM after carrageenan-induced paw edema. After 7.5\u00a0h, brain tissue was analyzed for neurons and astrocytes by IHC and Western blotting (anti-NF and anti-GFAP, respectively). Expression of proteoglycan (PG) core proteins and heparan sulfate (HS) metabolism-involved genes was determined by RT-PCR. The glycosaminoglycan (GAG) content was determined by dot blot and Alcian blue staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All studied drugs possessed similar anti-edema activity but differed in their effects on brain tissue. Unlike DXM, SEGRAs had no effect on neurofilament (NF) content in the mouse brain. Regarding astrocytes, although all drugs increased astrocyte number and outgrowth, only DXM and CpdA, but not CpdA-03, induced the appearance of a minor (44kDa) GFAP isoform associated with neurocognitive impairment. Neither DXM nor CpdA-03 affected the expression of genes coding PG core proteins and HS biosynthetic enzymes, and only CpdA upregulated the expression of syndecan-3, neurocan, aggrecan, and biglycan (2.5- to 3.5-fold). At the same time, all drugs decreased the content of total (1.5- to 2.8-fold) and sulfated (2- to 3-fold) GAGs, with the least effect observed for CpdA-03.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Between the two studied SEGRAs, CpdA shows more pronounced effects on the cellular and extracellular components of normal mouse brain tissue compared with DXM. CpdA-03 demonstrated the least effect on brain tissue and may be promising for further development as a less toxic replacement for glucocorticoids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1778726","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:33:09Z","timestamp":1783920789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective agonists of the glucocorticoid receptor (SEGRA) as an alternative to glucocorticoids: a pilot study of their effects on normal mouse brain tissue in the context of an acute peripheral inflammatory model in vivo"],"prefix":"10.3389","volume":"16","author":[{"given":"Stanislav D.","family":"Aladev","sequence":"first","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim O.","family":"Politko","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry K.","family":"Sokolov","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina M.","family":"Kazanskaya","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana V.","family":"Aidagulova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]},{"name":"Laboratory of Cellular Biology, Novosibirsk State Medical University","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira\u00a0V.","family":"Grigorieva","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine (FRC FTM)","place":["Novosibirsk, Russia"]},{"name":"Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071393","article-title":"Dexamethasone in patients with glioblastoma: a systematic review and meta-analysis","volume":"16","author":"Scheffler","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156794","article-title":"Dexamethasone in COVID-19 treatment: analyzing monotherapy and combination therapy approaches","volume":"184","author":"Meybodi","year":"2024","journal-title":"Cytokine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103625","article-title":"Advantages and drawbacks of dexamethasone in glioblastoma multiforme","volume":"172","author":"Afshari","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1335730","article-title":"Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms","volume":"13","author":"Mistry","year":"2023","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnmol.2019.00065","article-title":"Dexamethasone in glioblastoma multiforme therapy: mechanisms and controversies","volume":"12","author":"Cenciarini","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1632231","article-title":"Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit","volume":"16","author":"Prasad","year":"2025","journal-title":"Front Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jep.2017.03.019","article-title":"Sutherlandia frutescens modulates adrenal hormone biosynthesis, acts as a selective glucocorticoid receptor agonist (SEGRA) and displays anti-mineralcorticoid properties","volume":"202","author":"Sergeant","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14409","article-title":"How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids","volume":"596","author":"Strickland","year":"2022","journal-title":"FEBS Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1160238","article-title":"Phase-separation: a possible new layer for transcriptional regulation by glucocorticoid receptor","volume":"14","author":"Pinheiro","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/jep.s237480","article-title":"Experimental glucocorticoid receptor agonists for the treatment of asthma: a systematic review","volume":"12","author":"Rogliani","year":"2020","journal-title":"J Exp Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0368","article-title":"Interplay of the inflammatory and stress systems in hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6","volume":"151","author":"Visser","year":"2010","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","article-title":"Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.94.12.9992","article-title":"Antiinflommatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis","volume":"24","author":"van Loo","year":"2010","journal-title":"Mol Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-0991-y","article-title":"Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty","volume":"243","author":"Pleyer","year":"2005","journal-title":"Graefe\u2019s Arch For Clin Exp Ophtalmology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m112.400671","article-title":"Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1)","volume":"287","author":"Vollmer","year":"2012","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25011","article-title":"Evaluation of selective glucocorticoid receptor agonist compound A for ototoxic effects","volume":"125","author":"Honeder","year":"2015","journal-title":"Laryngoscope"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4161\/cc.23048","article-title":"Combination of a selective activator of the glucocorticoid receptor compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic Malignances","volume":"12","author":"Lesovaya","year":"2013","journal-title":"Cell Cycle"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5078","article-title":"Discovery of compound A \u2013 a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity","volume":"6","author":"Lesovaya","year":"2015","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/1178223420974667","article-title":"A brief overview of the paradoxical role of glucocorticoids in breast cancer","volume":"14","author":"Zhidkova","year":"2020","journal-title":"Breast Cancer (Auckl)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029756","article-title":"Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro","volume":"7","author":"Reuter","year":"2012","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.20944\/preprints202407.0030.v1","article-title":"Synthesis and anti-cancer activity of the novel selective glucocorticoid receptor agonists of the phenylethanolamine series","volume":"25","author":"Zhidkova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.17650\/2313-805x-2024-11-3-92-102","article-title":"Molecular mechanisms of novel selective glucocorticoid receptor agonist action in breast cancer cells","volume":"11","author":"Zhidkova","year":"2024","journal-title":"Adv In Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2006.11.006","article-title":"The growth plate sparing effects of selective glucocorticoid receptor modulator, AL-438","volume":"264","author":"Owen","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01104","article-title":"Conventional anti-glioblastoma chemotherapy affects proteoglycan composition of brain extracellular matrix in rat experimental model in vivo","volume":"9","author":"Tsidulko","year":"2018","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.713139","article-title":"Chemotherapy-induced degradation of glycosylated components of the brain extracellular matrix promotes glioblastoma relapse development in an animal model","volume":"11","author":"Tsidulko","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210243","article-title":"Dexamethasone inhibits heparan sulfate biosynthetic system and decreases heparan sulfate content in orthotopic glioblastoma tumors in mice","volume":"24","author":"Sokolov","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.17650\/2313-805x-2023-10-1-25-39","article-title":"Dexamethasone effects on the expression and content of glycosylated components of mouse brain tissue","volume":"10","author":"Aladev","year":"2023","journal-title":"Adv Mol Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/neurolint16040058","article-title":"Multiple administration of dexamethasone possesses a deferred long-term effect to glycosylated components of mouse brain","volume":"16","author":"Aladev","year":"2024","journal-title":"Neurol Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.32604\/biocell.2025.064100","article-title":"Dexamethasone effects on cell composition and myelin content in the mouse brain","volume":"49","author":"Aladev","year":"2025","journal-title":"BIOCELL"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12892","article-title":"Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice","volume":"171","author":"Saksida","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0006-8993(97)00612-4","article-title":"Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse","volume":"785","author":"Fujita","year":"1998","journal-title":"Brain Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00157","article-title":"Ultra-endurance associated with moderate exercise in rats induces cerebellar oxidative stress and impairs reactive GFAP isoform profile","volume":"13","author":"Souza","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1023\/a:1022476724381","article-title":"Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis","volume":"23","author":"Fujita","year":"1998","journal-title":"Neurochem Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"116018","DOI":"10.1016\/j.jep.2022.116018","article-title":"Antinociceptive and anti-inflammatory properties of aqueous extract obtained from Serjania marginata Casar leaves","volume":"304","author":"Leit\u00e3o","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.toxicon.2018.07.002","article-title":"The inhibitory effect of saPLI\u03b3, a snake sourced PLA2 inhibitor on carrageenan-induced inflammation in mice","volume":"151","author":"Zhang","year":"2018","journal-title":"Toxicon"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115173","article-title":"Antinociceptive, anti-inflammatory and antioxidant activities of the crude ethanolic extract and alkaloid fraction of Waltheria viscosissima A. St. -Hil. (Malvaceae)","volume":"292","author":"da Silva Dantas","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.02.001","article-title":"Pharmacology of glucocorticoids in rheumatoid arthritis","volume":"10","author":"Spies","year":"2010","journal-title":"Curr Opin Pharmacol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1778726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:05:49Z","timestamp":1784545549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1778726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":37,"alternative-id":["10.3389\/fonc.2026.1778726"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1778726","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1778726"}}